Glen Santangelo
Stock Analyst at Jefferies
(2.55)
# 2,355
Out of 5,090 analysts
78
Total ratings
50%
Success rate
2.15%
Average return
Main Sectors:
Stocks Rated by Glen Santangelo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HQY HealthEquity | Maintains: Buy | $130 → $134 | $94.51 | +41.78% | 6 | Sep 3, 2025 | |
| TDOC Teladoc Health | Maintains: Hold | $10 → $8 | $7.59 | +5.40% | 7 | Apr 21, 2025 | |
| ANIP ANI Pharmaceuticals | Initiates: Buy | $80 | $81.77 | -2.16% | 1 | Mar 14, 2025 | |
| VTRS Viatris | Maintains: Buy | $15 → $13 | $10.93 | +18.94% | 4 | Mar 7, 2025 | |
| WAY Waystar Holding | Initiates: Buy | $51 | $34.35 | +48.47% | 1 | Feb 11, 2025 | |
| XERS Xeris Biopharma Holdings | Reiterates: Buy | $4 → $6 | $6.51 | -7.83% | 2 | Jan 29, 2025 | |
| NVST Envista Holdings | Maintains: Hold | $20 → $22 | $20.23 | +8.75% | 1 | Jan 23, 2025 | |
| XRAY DENTSPLY SIRONA | Downgrades: Hold | $30 → $20 | $11.25 | +77.78% | 2 | Jan 23, 2025 | |
| PCRX Pacira BioSciences | Maintains: Buy | $15 → $18 | $23.99 | -24.97% | 5 | Sep 24, 2024 | |
| PGNY Progyny | Maintains: Buy | $31 → $24 | $24.02 | -0.08% | 4 | Sep 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $14 → $23 | $39.20 | -41.33% | 4 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $23 | $28.46 | -19.18% | 4 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $41 → $44 | $47.91 | -8.16% | 3 | Jun 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $17 | $21.90 | -22.37% | 1 | Dec 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $230 | $118.65 | +93.85% | 1 | Dec 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $8.81 | +1,035.07% | 2 | Dec 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $70 | $26.77 | +161.49% | 2 | Jul 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $55 | $40.50 | +35.80% | 1 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $14.58 | +9.74% | 1 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $78 → $46 | $45.93 | +0.15% | 2 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $31 → $28 | $2.60 | +976.92% | 2 | Mar 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $70 | $20.29 | +245.00% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $120 | $4.01 | +2,892.52% | 3 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $2 | $3.08 | -35.06% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $47 | $2.71 | +1,634.32% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $36 | $2.46 | +1,363.41% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $75.63 | - | 3 | Mar 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $173 → $169 | $808.62 | -79.10% | 5 | May 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $198.83 | - | 4 | Dec 16, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $79 → $82 | $73.62 | +11.38% | 2 | Apr 24, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $250 | $157.21 | +59.02% | 1 | Dec 8, 2017 |
HealthEquity
Sep 3, 2025
Maintains: Buy
Price Target: $130 → $134
Current: $94.51
Upside: +41.78%
Teladoc Health
Apr 21, 2025
Maintains: Hold
Price Target: $10 → $8
Current: $7.59
Upside: +5.40%
ANI Pharmaceuticals
Mar 14, 2025
Initiates: Buy
Price Target: $80
Current: $81.77
Upside: -2.16%
Viatris
Mar 7, 2025
Maintains: Buy
Price Target: $15 → $13
Current: $10.93
Upside: +18.94%
Waystar Holding
Feb 11, 2025
Initiates: Buy
Price Target: $51
Current: $34.35
Upside: +48.47%
Xeris Biopharma Holdings
Jan 29, 2025
Reiterates: Buy
Price Target: $4 → $6
Current: $6.51
Upside: -7.83%
Envista Holdings
Jan 23, 2025
Maintains: Hold
Price Target: $20 → $22
Current: $20.23
Upside: +8.75%
DENTSPLY SIRONA
Jan 23, 2025
Downgrades: Hold
Price Target: $30 → $20
Current: $11.25
Upside: +77.78%
Pacira BioSciences
Sep 24, 2024
Maintains: Buy
Price Target: $15 → $18
Current: $23.99
Upside: -24.97%
Progyny
Sep 19, 2024
Maintains: Buy
Price Target: $31 → $24
Current: $24.02
Upside: -0.08%
Jun 27, 2024
Maintains: Hold
Price Target: $14 → $23
Current: $39.20
Upside: -41.33%
Jun 27, 2024
Maintains: Buy
Price Target: $19 → $23
Current: $28.46
Upside: -19.18%
Jun 7, 2024
Upgrades: Buy
Price Target: $41 → $44
Current: $47.91
Upside: -8.16%
Dec 19, 2023
Initiates: Buy
Price Target: $17
Current: $21.90
Upside: -22.37%
Dec 19, 2023
Assumes: Buy
Price Target: $230
Current: $118.65
Upside: +93.85%
Dec 15, 2023
Reiterates: Buy
Price Target: $100
Current: $8.81
Upside: +1,035.07%
Jul 25, 2023
Reinstates: Buy
Price Target: $70
Current: $26.77
Upside: +161.49%
Oct 21, 2022
Initiates: Hold
Price Target: $55
Current: $40.50
Upside: +35.80%
Oct 21, 2022
Initiates: Buy
Price Target: $16
Current: $14.58
Upside: +9.74%
May 18, 2022
Maintains: Buy
Price Target: $78 → $46
Current: $45.93
Upside: +0.15%
Mar 17, 2022
Upgrades: Buy
Price Target: $31 → $28
Current: $2.60
Upside: +976.92%
Dec 2, 2021
Initiates: Buy
Price Target: $70
Current: $20.29
Upside: +245.00%
Dec 2, 2021
Initiates: Hold
Price Target: $120
Current: $4.01
Upside: +2,892.52%
Dec 2, 2021
Initiates: Hold
Price Target: $2
Current: $3.08
Upside: -35.06%
Dec 2, 2021
Initiates: Buy
Price Target: $47
Current: $2.71
Upside: +1,634.32%
Dec 2, 2021
Initiates: Buy
Price Target: $36
Current: $2.46
Upside: +1,363.41%
Mar 17, 2021
Downgrades: Neutral
Price Target: n/a
Current: $75.63
Upside: -
May 21, 2020
Maintains: Hold
Price Target: $173 → $169
Current: $808.62
Upside: -79.10%
Dec 16, 2019
Downgrades: Neutral
Price Target: n/a
Current: $198.83
Upside: -
Apr 24, 2018
Maintains: Buy
Price Target: $79 → $82
Current: $73.62
Upside: +11.38%
Dec 8, 2017
Initiates: Hold
Price Target: $250
Current: $157.21
Upside: +59.02%